Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic alterations in xeroderma pigmentosum patients.

A J Wysenbeek, H Weiss, M Duczyminer-Kahana

    Cancer
    |July 15, 1986
    PubMed
    Summary

    Patients with xeroderma pigmentosum (XP) exhibit immune system deficiencies, including reduced T-cell populations and impaired skin reactions. These immune alterations may increase cancer risk in XP patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort.

    Lupus·2002
    Same author

    Inactive systemic lupus erythematosus id associated with a normal stimulated Th(1)/Th(2) cytokine secretory pattern.

    Cytokine·2000
    Same author

    Headache in systemic lupus erythematosus and its relation to other disease manifestations.

    Clinical and experimental rheumatology·1999
    Same author

    Decreased expression of the p21ras stimulatory factor hSOS in PBMC from inactive SLE patients.

    Lupus·1999
    Same author

    Treatment of staphylococcal septic arthritis in rabbits by systemic antibiotics and intra-articular corticosteroids.

    Annals of the rheumatic diseases·1999
    Same author

    [Antiphospholipid antibody syndrome: clinical spectrum and pathogenesis].

    Harefuah·1998

    Area of Science:

    • Immunology
    • Genetics
    • Dermatology

    Background:

    • Xeroderma pigmentosum (XP) is a rare genetic disorder characterized by extreme sensitivity to ultraviolet (UV) radiation.
    • XP patients have a significantly increased risk of developing skin cancers and other malignancies.
    • The underlying mechanisms linking XP, UV exposure, and immune dysfunction are not fully understood.

    Purpose of the Study:

    • To investigate the immunological status of patients with xeroderma pigmentosum.
    • To explore potential correlations between UV sensitivity, immune alterations, and cancer susceptibility in XP.

    Main Methods:

    • Comparative analysis of immune cell subpopulations (e.g., OKT-4 lymphocytes) in XP patients versus healthy controls.
    • Assessment of lymphocyte responsiveness to phytohemagglutinin in autologous serum.

    Related Experiment Videos

  • Evaluation of delayed hypersensitivity skin reactions in XP patients.

    • Main Results:

    • XP patients displayed a reduced OKT-4 lymphocyte subpopulation compared to controls.
    • Lymphocyte response to phytohemagglutinin was diminished in XP patients.
    • Delayed hypersensitivity skin reactions were reduced in the investigated XP patient cohort.

    Conclusions:

    • XP patients exhibit significant immunologic alterations, including impaired T-cell function and reduced skin reactivity.
    • UV irradiation may contribute to these immune deficits in XP.
    • The observed immune dysregulation could be linked to the heightened susceptibility to malignant transformations in xeroderma pigmentosum.